Ketamine for substance use disorders: a systematic review and meta-analysis - Top-Institutions - MDSpire

Ketamine for substance use disorders: a systematic review and meta-analysis

  • By

  • Shu-Ping Fang

  • Xin Yang

  • Da-Cong Zhao

  • Yang Wen

  • Yi-Hao Liu

  • Zhe Li

  • Mao-Sheng Ran

  • July 17, 2026

Share

Top Institutions in Psychiatry

Brief introduction explaining scope and methodology.

  • #1

    New York State Psychiatric Institute, Columbia University Vagelos College of Physicians & Surgeons
    New York State Psychiatric Institute, Columbia University Vagelos College of Physicians & Surgeons

    New York, NY

    Key Differentiators

    • Psychiatry
    • Substance Use Disorders

  • #2

    Psychopharmacology and Addiction Research Centre, University of Exeter
    Psychopharmacology and Addiction Research Centre, University of Exeter

    Exeter, England

    Key Differentiators

    • Psychiatry
    • Addiction

  • #3

    University of Alabama at Birmingham
    University of Alabama at Birmingham

    Birmingham, AL

    Key Differentiators

    • Psychiatry

  • #4

    Medical University of Gdańsk
    Medical University of Gdańsk

    Gdańsk, Poland

    Key Differentiators

    • Psychiatry

  • #5

    OM1 Mental Health Specialty Network
    OM1 Mental Health Specialty Network

    Multiple Locations, USA

    Key Differentiators

    • Mental Health

Original Source(s)

Ketamine for substance use disorders: a systematic review and meta-analysis

  • by Shu-Ping Fang, Xin Yang, Da-Cong Zhao, Yang Wen, Yi-Hao Liu, Zhe Li, Mao-Sheng Ran

  • July 17, 2026

Related Content

Structure–activity relationship of synthetic cathinones: integrated in silico, in vitro, and in vivo studies of α-PiHP analogues

Jails are the frontline in fielding dangerous new type of drug withdrawal

Cost and Utilization of Inpatient Mental Health and Substance Use Treatment